

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.69977439 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.39377300 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.11377564 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.90119533 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.86199192 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.86199192 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.85158392 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.80632656 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.71301082 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.71301082 |
| 11 | lysine metabolic process (GO:0006553) | 4.32851429 |
| 12 | lysine catabolic process (GO:0006554) | 4.32851429 |
| 13 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.32317495 |
| 14 | mannose metabolic process (GO:0006013) | 4.29828004 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.17748619 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.17748619 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 4.15849671 |
| 18 | regulation of triglyceride catabolic process (GO:0010896) | 4.05992304 |
| 19 | kynurenine metabolic process (GO:0070189) | 3.94900539 |
| 20 | fatty acid transmembrane transport (GO:1902001) | 3.93184134 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.91085267 |
| 22 | glyoxylate metabolic process (GO:0046487) | 3.89905304 |
| 23 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.88411417 |
| 24 | bile acid biosynthetic process (GO:0006699) | 3.86141332 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.85391891 |
| 26 | cellular ketone body metabolic process (GO:0046950) | 3.85211050 |
| 27 | carnitine shuttle (GO:0006853) | 3.83556211 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.78691440 |
| 29 | acetyl-CoA metabolic process (GO:0006084) | 3.74996861 |
| 30 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.73005488 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 3.70568638 |
| 32 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.70388380 |
| 33 | 2-oxoglutarate metabolic process (GO:0006103) | 3.69733213 |
| 34 | urea metabolic process (GO:0019627) | 3.69647943 |
| 35 | urea cycle (GO:0000050) | 3.69647943 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 3.69374800 |
| 37 | amino-acid betaine metabolic process (GO:0006577) | 3.66584438 |
| 38 | fatty acid beta-oxidation (GO:0006635) | 3.66332913 |
| 39 | positive regulation of fatty acid oxidation (GO:0046321) | 3.58870728 |
| 40 | tryptophan catabolic process (GO:0006569) | 3.56942348 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 3.56942348 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 3.56942348 |
| 43 | aspartate family amino acid catabolic process (GO:0009068) | 3.55779307 |
| 44 | short-chain fatty acid metabolic process (GO:0046459) | 3.54701211 |
| 45 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.54044852 |
| 46 | positive regulation of lipid catabolic process (GO:0050996) | 3.53528415 |
| 47 | glutamate metabolic process (GO:0006536) | 3.51313064 |
| 48 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.48660110 |
| 49 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.46268139 |
| 50 | triglyceride homeostasis (GO:0070328) | 3.46147010 |
| 51 | acylglycerol homeostasis (GO:0055090) | 3.46147010 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.43823548 |
| 53 | fatty acid oxidation (GO:0019395) | 3.43040500 |
| 54 | cysteine metabolic process (GO:0006534) | 3.41333493 |
| 55 | fatty acid catabolic process (GO:0009062) | 3.39313647 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 3.39285449 |
| 57 | lipid oxidation (GO:0034440) | 3.38685723 |
| 58 | negative regulation of fibrinolysis (GO:0051918) | 3.37438917 |
| 59 | detection of bacterium (GO:0016045) | 3.37370298 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 3.36693036 |
| 61 | reverse cholesterol transport (GO:0043691) | 3.36553245 |
| 62 | regulation of fatty acid oxidation (GO:0046320) | 3.35257313 |
| 63 | complement activation, alternative pathway (GO:0006957) | 3.34282205 |
| 64 | serine family amino acid catabolic process (GO:0009071) | 3.33859389 |
| 65 | regulation of sequestering of triglyceride (GO:0010889) | 3.33734792 |
| 66 | bile acid metabolic process (GO:0008206) | 3.33095396 |
| 67 | ketone body metabolic process (GO:1902224) | 3.32978472 |
| 68 | protein-lipid complex remodeling (GO:0034368) | 3.32903200 |
| 69 | macromolecular complex remodeling (GO:0034367) | 3.32903200 |
| 70 | plasma lipoprotein particle remodeling (GO:0034369) | 3.32903200 |
| 71 | tryptophan metabolic process (GO:0006568) | 3.32176513 |
| 72 | regulation of cholesterol esterification (GO:0010872) | 3.29723219 |
| 73 | monocarboxylic acid catabolic process (GO:0072329) | 3.29005911 |
| 74 | neutrophil activation involved in immune response (GO:0002283) | 3.25441434 |
| 75 | response to muramyl dipeptide (GO:0032495) | 3.25223587 |
| 76 | positive thymic T cell selection (GO:0045059) | 3.24348933 |
| 77 | thymic T cell selection (GO:0045061) | 3.23478765 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 3.22444559 |
| 79 | biotin metabolic process (GO:0006768) | 3.21148874 |
| 80 | regulation of fibrinolysis (GO:0051917) | 3.20022499 |
| 81 | neutral lipid catabolic process (GO:0046461) | 3.19737878 |
| 82 | acylglycerol catabolic process (GO:0046464) | 3.19737878 |
| 83 | regulation of protein activation cascade (GO:2000257) | 3.18713164 |
| 84 | detection of other organism (GO:0098543) | 3.17991195 |
| 85 | homocysteine metabolic process (GO:0050667) | 3.16445494 |
| 86 | tricarboxylic acid cycle (GO:0006099) | 3.15899941 |
| 87 | carnitine metabolic process (GO:0009437) | 3.15730222 |
| 88 | tolerance induction (GO:0002507) | 3.13830400 |
| 89 | coenzyme catabolic process (GO:0009109) | 3.12942997 |
| 90 | phospholipid efflux (GO:0033700) | 3.12919543 |
| 91 | succinate metabolic process (GO:0006105) | 3.12127640 |
| 92 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.11258784 |
| 93 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.11258784 |
| 94 | modulation by symbiont of host immune response (GO:0052553) | 3.11258784 |
| 95 | positive regulation by symbiont of host defense response (GO:0052509) | 3.11258784 |
| 96 | modulation by symbiont of host defense response (GO:0052031) | 3.11258784 |
| 97 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.11258784 |
| 98 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.11115382 |
| 99 | protein carboxylation (GO:0018214) | 3.11115382 |
| 100 | tyrosine metabolic process (GO:0006570) | 3.08521789 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.06851092 |
| 102 | valine metabolic process (GO:0006573) | 3.06618935 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.06183498 |
| 104 | dicarboxylic acid catabolic process (GO:0043649) | 3.05723154 |
| 105 | negative regulation of cholesterol transport (GO:0032375) | 3.05365424 |
| 106 | negative regulation of sterol transport (GO:0032372) | 3.05365424 |
| 107 | carnitine transmembrane transport (GO:1902603) | 3.04593574 |
| 108 | cellular modified amino acid catabolic process (GO:0042219) | 3.03388902 |
| 109 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.02807843 |
| 110 | organic acid catabolic process (GO:0016054) | 3.01965352 |
| 111 | carboxylic acid catabolic process (GO:0046395) | 3.01965352 |
| 112 | triglyceride catabolic process (GO:0019433) | 3.00211024 |
| 113 | ethanol oxidation (GO:0006069) | 2.99526667 |
| 114 | regulation of leukocyte degranulation (GO:0043300) | 2.99410184 |
| 115 | germinal center formation (GO:0002467) | 2.98803856 |
| 116 | drug catabolic process (GO:0042737) | 2.98734890 |
| 117 | regulation of complement activation (GO:0030449) | 2.98429022 |
| 118 | branched-chain amino acid catabolic process (GO:0009083) | 2.98285504 |
| 119 | NADH metabolic process (GO:0006734) | 2.97850844 |
| 120 | aromatic amino acid family metabolic process (GO:0009072) | 2.97821328 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 2.97214296 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 2.95512395 |
| 123 | regulation of mast cell degranulation (GO:0043304) | 2.95274915 |
| 124 | carnitine transport (GO:0015879) | 2.93643169 |
| 125 | amino-acid betaine transport (GO:0015838) | 2.93643169 |
| 126 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.93464948 |
| 127 | fatty acid homeostasis (GO:0055089) | 2.92228634 |
| 128 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.91108355 |
| 129 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.88464072 |
| 130 | signal complex assembly (GO:0007172) | 2.86917705 |
| 131 | thioester biosynthetic process (GO:0035384) | 2.86528319 |
| 132 | acyl-CoA biosynthetic process (GO:0071616) | 2.86528319 |
| 133 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.85585216 |
| 134 | leukocyte aggregation (GO:0070486) | 2.79996252 |
| 135 | T cell selection (GO:0045058) | 2.78648485 |
| 136 | negative thymic T cell selection (GO:0045060) | 2.75478360 |
| 137 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.70828613 |
| 138 | megakaryocyte development (GO:0035855) | 2.69832261 |
| 139 | histone H3-K36 demethylation (GO:0070544) | 2.65787531 |
| 140 | adenosine receptor signaling pathway (GO:0001973) | 2.64156048 |
| 141 | negative regulation of myotube differentiation (GO:0010832) | 2.63866571 |
| 142 | B cell receptor signaling pathway (GO:0050853) | 2.63127527 |
| 143 | response to peptidoglycan (GO:0032494) | 2.61062799 |
| 144 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.60843488 |
| 145 | positive regulation of histone deacetylation (GO:0031065) | 2.58821275 |
| 146 | positive regulation of receptor recycling (GO:0001921) | 2.57911247 |
| 147 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.57664329 |
| 148 | negative T cell selection (GO:0043383) | 2.57620949 |
| 149 | positive regulation of Rap GTPase activity (GO:0032854) | 2.54502141 |
| 150 | regulation of integrin activation (GO:0033623) | 2.54225605 |
| 151 | regulation of ARF GTPase activity (GO:0032312) | 2.53826740 |
| 152 | macrophage activation involved in immune response (GO:0002281) | 2.53057457 |
| 153 | oxygen transport (GO:0015671) | 2.50247461 |
| 154 | activation of Rac GTPase activity (GO:0032863) | 2.48992256 |
| 155 | positive regulation of antigen processing and presentation (GO:0002579) | 2.48617972 |
| 156 | regulation of regulated secretory pathway (GO:1903305) | 2.48451935 |
| 157 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.48315822 |
| 158 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.47510534 |
| 159 | regulation of ARF protein signal transduction (GO:0032012) | 2.46469794 |
| 160 | regulation of platelet aggregation (GO:0090330) | 2.45246767 |
| 161 | regulation of necroptotic process (GO:0060544) | 2.44296705 |
| 162 | protein localization to endosome (GO:0036010) | 2.43798420 |
| 163 | neutrophil activation (GO:0042119) | 2.43034911 |
| 164 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.42329680 |
| 165 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.41614908 |
| 166 | apoptotic process involved in morphogenesis (GO:0060561) | 2.40611265 |
| 167 | phospholipid scrambling (GO:0017121) | 2.38580625 |
| 168 | modulation by virus of host process (GO:0019054) | 2.38235280 |
| 169 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.37132898 |
| 170 | detection of external biotic stimulus (GO:0098581) | 2.35758289 |
| 171 | negative regulation of viral release from host cell (GO:1902187) | 2.35175752 |
| 172 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.34941364 |
| 173 | regulation of chromatin binding (GO:0035561) | 2.34649777 |
| 174 | positive T cell selection (GO:0043368) | 2.34622623 |
| 175 | regulation of defense response to virus by virus (GO:0050690) | 2.34441365 |
| 176 | negative regulation of innate immune response (GO:0045824) | 2.34351693 |
| 177 | NIK/NF-kappaB signaling (GO:0038061) | 2.34235996 |
| 178 | platelet formation (GO:0030220) | 2.33027400 |
| 179 | proline biosynthetic process (GO:0006561) | 2.32599155 |
| 180 | positive regulation of B cell differentiation (GO:0045579) | 2.31481502 |
| 181 | peptide catabolic process (GO:0043171) | 2.30360721 |
| 182 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.30123222 |
| 183 | histone H4 deacetylation (GO:0070933) | 2.29952370 |
| 184 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.28829471 |
| 185 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.28177415 |
| 186 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.27227613 |
| 187 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.26730785 |
| 188 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.26062183 |
| 189 | gas transport (GO:0015669) | 2.25582621 |
| 190 | barbed-end actin filament capping (GO:0051016) | 2.25520874 |
| 191 | cellular response to virus (GO:0098586) | 2.25212895 |
| 192 | N-acetylneuraminate metabolic process (GO:0006054) | 2.24724497 |
| 193 | actin filament polymerization (GO:0030041) | 2.24106693 |
| 194 | granulocyte activation (GO:0036230) | 2.23885644 |
| 195 | regulation of necrotic cell death (GO:0010939) | 2.23500263 |
| 196 | activation of JUN kinase activity (GO:0007257) | 2.22720117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.85848731 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.66812981 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.84216095 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.09916777 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.94136421 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.35103886 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.08910704 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.08007996 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.81926590 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.73663841 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.72937227 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.47951570 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.40300397 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.38490165 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.37362981 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.29352580 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.19904948 |
| 18 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19492960 |
| 19 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.15778171 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01728370 |
| 21 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.00279771 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97244878 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95658333 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93119996 |
| 25 | P68_20966046_ChIP-Seq_HELA_Human | 1.89472331 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.88171442 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87123379 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.85522630 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.82643410 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.80798774 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80054679 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79339678 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77194052 |
| 34 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.76847378 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75982076 |
| 36 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.72872525 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.72216903 |
| 38 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.70954232 |
| 39 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.70487946 |
| 40 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.69108428 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67369185 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.64229701 |
| 43 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63489266 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.63015553 |
| 45 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.63015553 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.62098179 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61726345 |
| 48 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.61035418 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.60286678 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.59710551 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58704014 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58626763 |
| 53 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.56065010 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55250488 |
| 55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55083584 |
| 56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.54973596 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.53072420 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52953351 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52905627 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50317786 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47256309 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47209598 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47059765 |
| 64 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.45996772 |
| 65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.45216665 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44267407 |
| 67 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.43938517 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43659264 |
| 69 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.40839045 |
| 70 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.39779546 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37558711 |
| 72 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.37547367 |
| 73 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35673735 |
| 74 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.35615209 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35450539 |
| 76 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.34291573 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33746349 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33436131 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.33305896 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33280788 |
| 81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.33152302 |
| 82 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32743612 |
| 83 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30359929 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28897253 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28290429 |
| 86 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.26951316 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26151263 |
| 88 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25786546 |
| 89 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25487204 |
| 90 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.25344502 |
| 91 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24256258 |
| 92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23948706 |
| 93 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23271016 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22715212 |
| 95 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22248419 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22242342 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21372969 |
| 98 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21100275 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20864833 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20718235 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20475436 |
| 102 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.18036171 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17947523 |
| 104 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17942123 |
| 105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17210232 |
| 106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16797296 |
| 107 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16428243 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16252469 |
| 109 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14118087 |
| 110 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.13992258 |
| 111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13840048 |
| 112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.13363555 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12408474 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11835500 |
| 115 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11335729 |
| 116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11210422 |
| 117 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10824766 |
| 118 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10241325 |
| 119 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10171564 |
| 120 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09920504 |
| 121 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.09543457 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09127719 |
| 123 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.08751758 |
| 124 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07942325 |
| 125 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07810802 |
| 126 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06567485 |
| 127 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05855495 |
| 128 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05436204 |
| 129 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05348596 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03278417 |
| 131 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02666207 |
| 132 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.02602494 |
| 133 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98490252 |
| 134 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98284558 |
| 135 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95672469 |
| 136 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95672469 |
| 137 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94771924 |
| 138 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94597313 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92952535 |
| 140 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92705144 |
| 141 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92514403 |
| 142 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90472408 |
| 143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90151867 |
| 144 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90082769 |
| 145 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.88195771 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86849680 |
| 147 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86819431 |
| 148 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85590537 |
| 149 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84153992 |
| 150 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83055156 |
| 151 | AR_19668381_ChIP-Seq_PC3_Human | 0.82022343 |
| 152 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81562691 |
| 153 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.80217848 |
| 154 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.79105397 |
| 155 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77297304 |
| 156 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76360908 |
| 157 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.74966193 |
| 158 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74017124 |
| 159 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.73930228 |
| 160 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.73767570 |
| 161 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.72242986 |
| 162 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.71635708 |
| 163 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.71363698 |
| 164 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.71115364 |
| 165 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.70954175 |
| 166 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70906375 |
| 167 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70906375 |
| 168 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.70640220 |
| 169 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.70393412 |
| 170 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.70377485 |
| 171 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.69448895 |
| 172 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69289544 |
| 173 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.69217747 |
| 174 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.69082801 |
| 175 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.68451918 |
| 176 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.68297620 |
| 177 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.68079458 |
| 178 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.67155862 |
| 179 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.66041696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.64882076 |
| 2 | MP0005360_urolithiasis | 5.17621072 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.38183076 |
| 4 | MP0005365_abnormal_bile_salt | 4.20468282 |
| 5 | MP0003436_decreased_susceptibility_to | 3.30693920 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.30679841 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 3.24155435 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.14121925 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.70277929 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.67127197 |
| 11 | MP0004130_abnormal_muscle_cell | 2.65058188 |
| 12 | MP0003252_abnormal_bile_duct | 2.60910500 |
| 13 | MP0004859_abnormal_synaptic_plasticity | 2.60735570 |
| 14 | MP0008260_abnormal_autophagy | 2.60252133 |
| 15 | MP0001849_ear_inflammation | 2.58278866 |
| 16 | MP0003303_peritoneal_inflammation | 2.48240932 |
| 17 | MP0009840_abnormal_foam_cell | 2.34395154 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.32032207 |
| 19 | MP0003724_increased_susceptibility_to | 2.29183722 |
| 20 | MP0005332_abnormal_amino_acid | 2.28716142 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.28215718 |
| 22 | MP0005670_abnormal_white_adipose | 2.27877653 |
| 23 | MP0004147_increased_porphyrin_level | 2.20257579 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.17530431 |
| 25 | MP0004947_skin_inflammation | 2.13742912 |
| 26 | MP0009278_abnormal_bone_marrow | 2.07853433 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.05464036 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.04377413 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.98281736 |
| 30 | MP0005083_abnormal_biliary_tract | 1.97092959 |
| 31 | MP0003329_amyloid_beta_deposits | 1.84654123 |
| 32 | MP0000751_myopathy | 1.83599751 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.81891592 |
| 34 | MP0005025_abnormal_response_to | 1.81795250 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.81251616 |
| 36 | MP0003646_muscle_fatigue | 1.80671035 |
| 37 | MP0002822_catalepsy | 1.79572535 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.79039542 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.76589315 |
| 40 | MP0001800_abnormal_humoral_immune | 1.73917972 |
| 41 | MP0002419_abnormal_innate_immunity | 1.73811703 |
| 42 | MP0000685_abnormal_immune_system | 1.73226487 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.71960043 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.67529168 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.64360891 |
| 46 | MP0001873_stomach_inflammation | 1.62357071 |
| 47 | MP0001348_abnormal_lacrimal_gland | 1.62237984 |
| 48 | MP0001790_abnormal_immune_system | 1.60453458 |
| 49 | MP0005387_immune_system_phenotype | 1.60453458 |
| 50 | MP0003635_abnormal_synaptic_transmissio | 1.60060390 |
| 51 | MP0002723_abnormal_immune_serum | 1.57858649 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.56620161 |
| 53 | MP0003866_abnormal_defecation | 1.56507868 |
| 54 | MP0003195_calcinosis | 1.56004197 |
| 55 | MP0004215_abnormal_myocardial_fiber | 1.55814603 |
| 56 | MP0005535_abnormal_body_temperature | 1.54662565 |
| 57 | MP0001819_abnormal_immune_cell | 1.53786302 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.53627439 |
| 59 | MP0000609_abnormal_liver_physiology | 1.51425286 |
| 60 | MP0002398_abnormal_bone_marrow | 1.51011714 |
| 61 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.50724402 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.49907393 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.47701296 |
| 64 | MP0002971_abnormal_brown_adipose | 1.45556499 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 1.43888763 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.43230362 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.43230362 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.40674831 |
| 69 | MP0000858_altered_metastatic_potential | 1.40143044 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.37583101 |
| 71 | MP0005671_abnormal_response_to | 1.36780291 |
| 72 | MP0000678_abnormal_parathyroid_gland | 1.36219240 |
| 73 | MP0009745_abnormal_behavioral_response | 1.32086981 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.31419438 |
| 75 | MP0004084_abnormal_cardiac_muscle | 1.31035937 |
| 76 | MP0005330_cardiomyopathy | 1.30678489 |
| 77 | MP0000604_amyloidosis | 1.29322123 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 1.28998610 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 1.28437212 |
| 80 | MP0002909_abnormal_adrenal_gland | 1.27625321 |
| 81 | MP0000716_abnormal_immune_system | 1.27583462 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 1.27392934 |
| 83 | MP0000490_abnormal_crypts_of | 1.27357434 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 1.26382628 |
| 85 | MP0002396_abnormal_hematopoietic_system | 1.26012166 |
| 86 | MP0003690_abnormal_glial_cell | 1.25034922 |
| 87 | MP0004270_analgesia | 1.23750612 |
| 88 | MP0004036_abnormal_muscle_relaxation | 1.23675364 |
| 89 | MP0009785_altered_susceptibility_to | 1.23202906 |
| 90 | MP0002063_abnormal_learning/memory/cond | 1.22977061 |
| 91 | MP0001851_eye_inflammation | 1.22481581 |
| 92 | MP0000703_abnormal_thymus_morphology | 1.21601489 |
| 93 | MP0002064_seizures | 1.21492464 |
| 94 | MP0002722_abnormal_immune_system | 1.21373670 |
| 95 | MP0002429_abnormal_blood_cell | 1.21019664 |
| 96 | MP0009046_muscle_twitch | 1.20509872 |
| 97 | MP0005409_darkened_coat_color | 1.20183898 |
| 98 | MP0001501_abnormal_sleep_pattern | 1.18604313 |
| 99 | MP0004510_myositis | 1.17715019 |
| 100 | MP0005375_adipose_tissue_phenotype | 1.17607974 |
| 101 | MP0001663_abnormal_digestive_system | 1.16345172 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 1.13751816 |
| 103 | MP0006036_abnormal_mitochondrial_physio | 1.13418511 |
| 104 | MP0004381_abnormal_hair_follicle | 1.12957256 |
| 105 | MP0003879_abnormal_hair_cell | 1.12060189 |
| 106 | MP0001845_abnormal_inflammatory_respons | 1.11072597 |
| 107 | MP0002132_abnormal_respiratory_system | 1.09497324 |
| 108 | MP0002998_abnormal_bone_remodeling | 1.08808270 |
| 109 | MP0005334_abnormal_fat_pad | 1.08558824 |
| 110 | MP0003137_abnormal_impulse_conducting | 1.08411726 |
| 111 | MP0003880_abnormal_central_pattern | 1.07738387 |
| 112 | MP0000689_abnormal_spleen_morphology | 1.07582637 |
| 113 | MP0005448_abnormal_energy_balance | 1.06447478 |
| 114 | MP0004858_abnormal_nervous_system | 1.02497985 |
| 115 | MP0002876_abnormal_thyroid_physiology | 1.00985611 |
| 116 | MP0006138_congestive_heart_failure | 1.00184928 |
| 117 | MP0008961_abnormal_basal_metabolism | 0.99839649 |
| 118 | MP0002933_joint_inflammation | 0.99828948 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.99824437 |
| 120 | MP0002972_abnormal_cardiac_muscle | 0.98864910 |
| 121 | MP0005620_abnormal_muscle_contractility | 0.98077785 |
| 122 | MP0003828_pulmonary_edema | 0.97796799 |
| 123 | MP0004087_abnormal_muscle_fiber | 0.96534479 |
| 124 | MP0002272_abnormal_nervous_system | 0.96403853 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.95935155 |
| 126 | MP0002269_muscular_atrophy | 0.94608371 |
| 127 | MP0001764_abnormal_homeostasis | 0.94590555 |
| 128 | MP0002572_abnormal_emotion/affect_behav | 0.94067333 |
| 129 | MP0002405_respiratory_system_inflammati | 0.94036542 |
| 130 | MP0004085_abnormal_heartbeat | 0.93708165 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.92553712 |
| 132 | MP0001440_abnormal_grooming_behavior | 0.92324459 |
| 133 | MP0001486_abnormal_startle_reflex | 0.91723175 |
| 134 | MP0002796_impaired_skin_barrier | 0.90950843 |
| 135 | MP0005501_abnormal_skin_physiology | 0.90197966 |
| 136 | MP0003045_fibrosis | 0.90137745 |
| 137 | MP0000749_muscle_degeneration | 0.89964843 |
| 138 | MP0003868_abnormal_feces_composition | 0.89388279 |
| 139 | MP0005451_abnormal_body_composition | 0.88684298 |
| 140 | MP0005381_digestive/alimentary_phenotyp | 0.85958396 |
| 141 | MP0004924_abnormal_behavior | 0.85766594 |
| 142 | MP0005386_behavior/neurological_phenoty | 0.85766594 |
| 143 | MP0002148_abnormal_hypersensitivity_rea | 0.85584442 |
| 144 | MP0001544_abnormal_cardiovascular_syste | 0.83346772 |
| 145 | MP0005385_cardiovascular_system_phenoty | 0.83346772 |
| 146 | MP0003633_abnormal_nervous_system | 0.82850883 |
| 147 | MP0001968_abnormal_touch/_nociception | 0.82639657 |
| 148 | MP0008874_decreased_physiological_sensi | 0.82248055 |
| 149 | MP0000747_muscle_weakness | 0.81886273 |
| 150 | MP0006035_abnormal_mitochondrial_morpho | 0.81236968 |
| 151 | MP0008469_abnormal_protein_level | 0.80198604 |
| 152 | MP0009931_abnormal_skin_appearance | 0.79811140 |
| 153 | MP0002166_altered_tumor_susceptibility | 0.79028680 |
| 154 | MP0009643_abnormal_urine_homeostasis | 0.77992199 |
| 155 | MP0000249_abnormal_blood_vessel | 0.76151361 |
| 156 | MP0001765_abnormal_ion_homeostasis | 0.76146993 |
| 157 | MP0008872_abnormal_physiological_respon | 0.74235485 |
| 158 | MP0000003_abnormal_adipose_tissue | 0.73733894 |
| 159 | MP0008004_abnormal_stomach_pH | 0.73611168 |
| 160 | MP0000230_abnormal_systemic_arterial | 0.73165931 |
| 161 | MP0002009_preneoplasia | 0.72505050 |
| 162 | MP0000681_abnormal_thyroid_gland | 0.71869832 |
| 163 | MP0003091_abnormal_cell_migration | 0.71598873 |
| 164 | MP0010234_abnormal_vibrissa_follicle | 0.70665434 |
| 165 | MP0005310_abnormal_salivary_gland | 0.70651411 |
| 166 | MP0003953_abnormal_hormone_level | 0.70630314 |
| 167 | MP0002734_abnormal_mechanical_nocicepti | 0.70341988 |
| 168 | MP0009115_abnormal_fat_cell | 0.69321551 |
| 169 | MP0002090_abnormal_vision | 0.68770972 |
| 170 | MP0009697_abnormal_copulation | 0.68674870 |
| 171 | MP0003075_altered_response_to | 0.68588796 |
| 172 | MP0005167_abnormal_blood-brain_barrier | 0.68427306 |
| 173 | MP0004043_abnormal_pH_regulation | 0.68193807 |
| 174 | MP0003656_abnormal_erythrocyte_physiolo | 0.67758984 |
| 175 | MP0002069_abnormal_eating/drinking_beha | 0.66285610 |
| 176 | MP0005266_abnormal_metabolism | 0.65235030 |
| 177 | MP0002733_abnormal_thermal_nociception | 0.65199235 |
| 178 | MP0003631_nervous_system_phenotype | 0.65001302 |
| 179 | MP0004145_abnormal_muscle_electrophysio | 0.64852412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.83088670 |
| 2 | Xanthomatosis (HP:0000991) | 4.54360501 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.38821212 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.27602551 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.24995350 |
| 6 | Hyperglycinuria (HP:0003108) | 4.15071590 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.14094335 |
| 8 | Ketosis (HP:0001946) | 4.10704475 |
| 9 | Hyperammonemia (HP:0001987) | 4.02740747 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 3.89691769 |
| 11 | Prolonged bleeding time (HP:0003010) | 3.88474194 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 3.82829793 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82829793 |
| 14 | Ketoacidosis (HP:0001993) | 3.72416000 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.70696771 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.64922603 |
| 17 | Epidermoid cyst (HP:0200040) | 3.58970734 |
| 18 | Hyperglycinemia (HP:0002154) | 3.56314244 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.50647708 |
| 20 | Prolonged partial thromboplastin time (HP:0003645) | 3.49884939 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.43977067 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36430458 |
| 23 | Complement deficiency (HP:0004431) | 3.35719178 |
| 24 | Myoglobinuria (HP:0002913) | 3.19574872 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.13745315 |
| 26 | Petechiae (HP:0000967) | 3.12146624 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.10027814 |
| 28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.00092304 |
| 29 | Abnormality of the fingertips (HP:0001211) | 2.95439036 |
| 30 | Obstructive sleep apnea (HP:0002870) | 2.89738003 |
| 31 | Reticulocytosis (HP:0001923) | 2.88639029 |
| 32 | Purpura (HP:0000979) | 2.80801529 |
| 33 | Sudden death (HP:0001699) | 2.79906503 |
| 34 | Epistaxis (HP:0000421) | 2.78393743 |
| 35 | Skin nodule (HP:0200036) | 2.75539285 |
| 36 | Hemorrhage of the eye (HP:0011885) | 2.75015397 |
| 37 | Increased IgE level (HP:0003212) | 2.74756607 |
| 38 | Abnormal platelet volume (HP:0011876) | 2.71481537 |
| 39 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.70943524 |
| 40 | Dicarboxylic aciduria (HP:0003215) | 2.70943524 |
| 41 | Breast hypoplasia (HP:0003187) | 2.70867526 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.67892246 |
| 43 | Colitis (HP:0002583) | 2.65837114 |
| 44 | Broad face (HP:0000283) | 2.65551392 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 2.65220343 |
| 46 | Exercise-induced myalgia (HP:0003738) | 2.64697019 |
| 47 | Menorrhagia (HP:0000132) | 2.64346950 |
| 48 | Cellulitis (HP:0100658) | 2.63666713 |
| 49 | Focal motor seizures (HP:0011153) | 2.61603610 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.59696081 |
| 51 | Pustule (HP:0200039) | 2.59214507 |
| 52 | Hypercholesterolemia (HP:0003124) | 2.56125842 |
| 53 | Myokymia (HP:0002411) | 2.55376007 |
| 54 | Thin bony cortex (HP:0002753) | 2.55230566 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.54675472 |
| 56 | Obstructive lung disease (HP:0006536) | 2.54675472 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.54620500 |
| 58 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.54016206 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.53227763 |
| 60 | Malnutrition (HP:0004395) | 2.49063054 |
| 61 | Gastrointestinal infarctions (HP:0005244) | 2.48004390 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 2.46409961 |
| 63 | Increased connective tissue (HP:0009025) | 2.44545287 |
| 64 | Delayed CNS myelination (HP:0002188) | 2.40368689 |
| 65 | Cholelithiasis (HP:0001081) | 2.39408435 |
| 66 | Metabolic acidosis (HP:0001942) | 2.39406353 |
| 67 | Increased serum ferritin (HP:0003281) | 2.38659337 |
| 68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.37306340 |
| 69 | Gingivitis (HP:0000230) | 2.37204272 |
| 70 | Increased mean platelet volume (HP:0011877) | 2.36831427 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.35643568 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.35531320 |
| 73 | Cholecystitis (HP:0001082) | 2.35531320 |
| 74 | Recurrent fungal infections (HP:0002841) | 2.33692267 |
| 75 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.32328944 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.31480826 |
| 77 | Cerebral edema (HP:0002181) | 2.31093331 |
| 78 | Distal lower limb muscle weakness (HP:0009053) | 2.30246185 |
| 79 | Myositis (HP:0100614) | 2.29059845 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.28318476 |
| 81 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.26598289 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.26233980 |
| 83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26022871 |
| 84 | Status epilepticus (HP:0002133) | 2.25313742 |
| 85 | Abnormality of the lower motor neuron (HP:0002366) | 2.24969280 |
| 86 | Joint hemorrhage (HP:0005261) | 2.24776436 |
| 87 | Hyperacusis (HP:0010780) | 2.24525569 |
| 88 | Hyperbilirubinemia (HP:0002904) | 2.24458988 |
| 89 | Spontaneous hematomas (HP:0007420) | 2.23557614 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.23538703 |
| 91 | Gout (HP:0001997) | 2.22662650 |
| 92 | J-shaped sella turcica (HP:0002680) | 2.22595148 |
| 93 | Lethargy (HP:0001254) | 2.22347471 |
| 94 | Neonatal onset (HP:0003623) | 2.22294586 |
| 95 | Polycythemia (HP:0001901) | 2.21868267 |
| 96 | Meningitis (HP:0001287) | 2.21295636 |
| 97 | Abnormality of complement system (HP:0005339) | 2.18342411 |
| 98 | Poikilocytosis (HP:0004447) | 2.17558302 |
| 99 | Easy fatigability (HP:0003388) | 2.16337738 |
| 100 | Bundle branch block (HP:0011710) | 2.15763309 |
| 101 | Stridor (HP:0010307) | 2.15519580 |
| 102 | Fat malabsorption (HP:0002630) | 2.15419620 |
| 103 | Rhabdomyolysis (HP:0003201) | 2.14950900 |
| 104 | Ventricular fibrillation (HP:0001663) | 2.14861280 |
| 105 | Abnormal social behavior (HP:0012433) | 2.14553140 |
| 106 | Impaired social interactions (HP:0000735) | 2.14553140 |
| 107 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.13738471 |
| 108 | Oligomenorrhea (HP:0000876) | 2.13551740 |
| 109 | Abnormality of iron homeostasis (HP:0011031) | 2.12733115 |
| 110 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12507635 |
| 111 | Pheochromocytoma (HP:0002666) | 2.12434163 |
| 112 | Atrioventricular block (HP:0001678) | 2.11745622 |
| 113 | Syncope (HP:0001279) | 2.09990600 |
| 114 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08712875 |
| 115 | Gastrointestinal dysmotility (HP:0002579) | 2.07953038 |
| 116 | Panhypogammaglobulinemia (HP:0003139) | 2.07241086 |
| 117 | Hydroxyprolinuria (HP:0003080) | 2.05330923 |
| 118 | Abnormality of proline metabolism (HP:0010907) | 2.05330923 |
| 119 | Right ventricular cardiomyopathy (HP:0011663) | 2.04093473 |
| 120 | Disproportionate tall stature (HP:0001519) | 2.03543752 |
| 121 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03348532 |
| 122 | Hyperventilation (HP:0002883) | 2.03081884 |
| 123 | Abnormality of purine metabolism (HP:0004352) | 2.02171400 |
| 124 | Hypoglycemic seizures (HP:0002173) | 2.01977441 |
| 125 | Dysmetric saccades (HP:0000641) | 2.01877610 |
| 126 | Recurrent viral infections (HP:0004429) | 2.01861682 |
| 127 | Myopathic facies (HP:0002058) | 2.01579249 |
| 128 | Agammaglobulinemia (HP:0004432) | 1.99653893 |
| 129 | Focal seizures (HP:0007359) | 1.97921546 |
| 130 | Metaphyseal cupping (HP:0003021) | 1.97867671 |
| 131 | Visual hallucinations (HP:0002367) | 1.97769000 |
| 132 | Impaired platelet aggregation (HP:0003540) | 1.97176027 |
| 133 | Abnormal platelet function (HP:0011869) | 1.97176027 |
| 134 | Cerebral inclusion bodies (HP:0100314) | 1.96166956 |
| 135 | Heart block (HP:0012722) | 1.95872459 |
| 136 | Sensorimotor neuropathy (HP:0007141) | 1.95450508 |
| 137 | Late onset (HP:0003584) | 1.95140916 |
| 138 | Vomiting (HP:0002013) | 1.94368523 |
| 139 | Encephalitis (HP:0002383) | 1.93858825 |
| 140 | Abnormality of the thoracic spine (HP:0100711) | 1.92698374 |
| 141 | Ileus (HP:0002595) | 1.92309351 |
| 142 | Increased cerebral lipofuscin (HP:0011813) | 1.92051813 |
| 143 | Torticollis (HP:0000473) | 1.90757772 |
| 144 | Ventricular arrhythmia (HP:0004308) | 1.90360592 |
| 145 | Hyporeflexia of lower limbs (HP:0002600) | 1.90232755 |
| 146 | Conjugated hyperbilirubinemia (HP:0002908) | 1.90143371 |
| 147 | Palpitations (HP:0001962) | 1.89785794 |
| 148 | Neurofibrillary tangles (HP:0002185) | 1.89507427 |
| 149 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89107391 |
| 150 | Emphysema (HP:0002097) | 1.88965140 |
| 151 | Seborrheic dermatitis (HP:0001051) | 1.88894290 |
| 152 | Abnormality of the Achilles tendon (HP:0005109) | 1.88272941 |
| 153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88247466 |
| 154 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88247466 |
| 155 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88247466 |
| 156 | Ragged-red muscle fibers (HP:0003200) | 1.88194453 |
| 157 | Systemic lupus erythematosus (HP:0002725) | 1.87394933 |
| 158 | Osteomyelitis (HP:0002754) | 1.86107049 |
| 159 | Gingival bleeding (HP:0000225) | 1.86100455 |
| 160 | Gastrointestinal stroma tumor (HP:0100723) | 1.85536979 |
| 161 | Granulocytopenia (HP:0001913) | 1.85034200 |
| 162 | Upper limb amyotrophy (HP:0009129) | 1.84713081 |
| 163 | Distal upper limb amyotrophy (HP:0007149) | 1.84713081 |
| 164 | Slow saccadic eye movements (HP:0000514) | 1.84379330 |
| 165 | Hypertriglyceridemia (HP:0002155) | 1.83365715 |
| 166 | Abnormality of nucleobase metabolism (HP:0010932) | 1.82918435 |
| 167 | Neuroendocrine neoplasm (HP:0100634) | 1.82875212 |
| 168 | Orchitis (HP:0100796) | 1.82750724 |
| 169 | Hepatosplenomegaly (HP:0001433) | 1.81846573 |
| 170 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81646985 |
| 171 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81646985 |
| 172 | Hypertensive crisis (HP:0100735) | 1.81476241 |
| 173 | Poor eye contact (HP:0000817) | 1.81410436 |
| 174 | Action tremor (HP:0002345) | 1.80521415 |
| 175 | Craniofacial dystonia (HP:0012179) | 1.80041610 |
| 176 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79791398 |
| 177 | Increased muscle lipid content (HP:0009058) | 1.78614737 |
| 178 | Abnormal atrioventricular conduction (HP:0005150) | 1.78064222 |
| 179 | Generalized tonic-clonic seizures (HP:0002069) | 1.77905166 |
| 180 | Flat acetabular roof (HP:0003180) | 1.77862541 |
| 181 | Verrucae (HP:0200043) | 1.77639325 |
| 182 | Papilloma (HP:0012740) | 1.77639325 |
| 183 | Focal dystonia (HP:0004373) | 1.77545967 |
| 184 | Ankle clonus (HP:0011448) | 1.77273223 |
| 185 | Polygenic inheritance (HP:0010982) | 1.77212819 |
| 186 | Cerebral aneurysm (HP:0004944) | 1.77117947 |
| 187 | Cerebral hemorrhage (HP:0001342) | 1.76398583 |
| 188 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75766086 |
| 189 | Mucopolysacchariduria (HP:0008155) | 1.75766086 |
| 190 | Stomatitis (HP:0010280) | 1.75759959 |
| 191 | Atrial fibrillation (HP:0005110) | 1.75729979 |
| 192 | Cervical subluxation (HP:0003308) | 1.75371287 |
| 193 | Lymphangioma (HP:0100764) | 1.75112810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.86990730 |
| 2 | PRPF4B | 3.43949850 |
| 3 | RIPK4 | 3.41708700 |
| 4 | TRIB3 | 3.41588067 |
| 5 | EPHA4 | 2.91494289 |
| 6 | MAP4K1 | 2.64077017 |
| 7 | LMTK2 | 2.53464373 |
| 8 | SIK1 | 2.53163384 |
| 9 | INSRR | 2.51996239 |
| 10 | SMG1 | 2.48762151 |
| 11 | NTRK3 | 2.31029376 |
| 12 | DAPK2 | 2.25856282 |
| 13 | PKN2 | 2.22672303 |
| 14 | MAP2K4 | 2.21383071 |
| 15 | MAP2K3 | 2.19117469 |
| 16 | MAP3K4 | 1.98042334 |
| 17 | PHKG2 | 1.93978621 |
| 18 | PHKG1 | 1.93978621 |
| 19 | GRK6 | 1.81745542 |
| 20 | MAP3K11 | 1.80758639 |
| 21 | MAP3K13 | 1.78820000 |
| 22 | PDK3 | 1.78028963 |
| 23 | PDK4 | 1.78028963 |
| 24 | TNK2 | 1.70863783 |
| 25 | EEF2K | 1.66661707 |
| 26 | MAP3K9 | 1.66130836 |
| 27 | PAK6 | 1.65126701 |
| 28 | MINK1 | 1.64306875 |
| 29 | RIPK1 | 1.63061956 |
| 30 | ZAP70 | 1.61655076 |
| 31 | BMX | 1.59380058 |
| 32 | PINK1 | 1.57013677 |
| 33 | CAMK1D | 1.51047687 |
| 34 | KSR2 | 1.48258427 |
| 35 | FGFR4 | 1.45588952 |
| 36 | MAP3K10 | 1.44750452 |
| 37 | CAMK1G | 1.43042654 |
| 38 | CAMKK1 | 1.42750854 |
| 39 | MARK1 | 1.42434858 |
| 40 | BTK | 1.40063420 |
| 41 | FES | 1.39276863 |
| 42 | IRAK3 | 1.37487363 |
| 43 | NTRK2 | 1.37358926 |
| 44 | NTRK1 | 1.36127599 |
| 45 | ERN1 | 1.35862905 |
| 46 | TYK2 | 1.35306608 |
| 47 | NEK1 | 1.31056356 |
| 48 | PRKD3 | 1.30473634 |
| 49 | MAP3K7 | 1.29599520 |
| 50 | EPHB1 | 1.25353480 |
| 51 | STK38 | 1.22244740 |
| 52 | TBK1 | 1.22081774 |
| 53 | PRKD2 | 1.21598506 |
| 54 | PAK3 | 1.21114077 |
| 55 | MAP2K2 | 1.20362116 |
| 56 | TAOK2 | 1.19220001 |
| 57 | BLK | 1.19062129 |
| 58 | FGFR2 | 1.18863643 |
| 59 | TTN | 1.18286254 |
| 60 | MAP3K3 | 1.16852565 |
| 61 | CDK12 | 1.14721592 |
| 62 | LATS2 | 1.12360170 |
| 63 | MAP3K14 | 1.11429516 |
| 64 | RET | 1.09537201 |
| 65 | IRAK4 | 1.09523141 |
| 66 | JAK3 | 1.04960722 |
| 67 | TESK2 | 1.02648088 |
| 68 | SGK3 | 1.01189431 |
| 69 | PDGFRA | 1.00054756 |
| 70 | TYRO3 | 0.99695695 |
| 71 | SYK | 0.99314021 |
| 72 | SIK3 | 0.98434455 |
| 73 | PRKCH | 0.96035045 |
| 74 | PDPK1 | 0.93249010 |
| 75 | HCK | 0.93078723 |
| 76 | MAP2K7 | 0.90074184 |
| 77 | CDK5 | 0.89569060 |
| 78 | PRKAA2 | 0.89529332 |
| 79 | OBSCN | 0.85318935 |
| 80 | PRKAA1 | 0.85181280 |
| 81 | RPS6KL1 | 0.84051097 |
| 82 | RPS6KC1 | 0.84051097 |
| 83 | SGK494 | 0.83471016 |
| 84 | SGK223 | 0.83471016 |
| 85 | MAP3K6 | 0.82601922 |
| 86 | PRKCG | 0.81394792 |
| 87 | TAOK1 | 0.80123154 |
| 88 | CSK | 0.79388801 |
| 89 | KSR1 | 0.78801573 |
| 90 | ICK | 0.78258396 |
| 91 | PTK6 | 0.77765803 |
| 92 | CAMK1 | 0.77364749 |
| 93 | SGK2 | 0.76188140 |
| 94 | ITK | 0.76101824 |
| 95 | ERBB4 | 0.75338113 |
| 96 | MYLK | 0.75085239 |
| 97 | PDK2 | 0.74755266 |
| 98 | MAPK12 | 0.74380338 |
| 99 | PDK1 | 0.74233229 |
| 100 | MAP2K1 | 0.74070188 |
| 101 | PRKCZ | 0.73086884 |
| 102 | RPS6KA6 | 0.72218630 |
| 103 | IKBKE | 0.71387286 |
| 104 | CAMK4 | 0.70716274 |
| 105 | CAMK2A | 0.70087998 |
| 106 | PRKACG | 0.69882428 |
| 107 | PTK2B | 0.69560184 |
| 108 | CAMK2G | 0.69344691 |
| 109 | EPHA2 | 0.69201629 |
| 110 | MAP2K6 | 0.68178664 |
| 111 | JAK1 | 0.67480214 |
| 112 | FER | 0.66509157 |
| 113 | PRKD1 | 0.66033359 |
| 114 | SIK2 | 0.65841196 |
| 115 | PRKG2 | 0.65511936 |
| 116 | MST1R | 0.65146135 |
| 117 | CSF1R | 0.65057515 |
| 118 | DAPK1 | 0.63265133 |
| 119 | CAMK2D | 0.63083854 |
| 120 | HIPK2 | 0.62900106 |
| 121 | MAP3K2 | 0.61845581 |
| 122 | GRK5 | 0.61146411 |
| 123 | TXK | 0.60962961 |
| 124 | ACVR1B | 0.60873182 |
| 125 | TIE1 | 0.60727884 |
| 126 | PIK3CA | 0.60711537 |
| 127 | STK11 | 0.59225585 |
| 128 | FGR | 0.59069617 |
| 129 | MAPK7 | 0.58294736 |
| 130 | IKBKB | 0.57889845 |
| 131 | MAPK11 | 0.55304082 |
| 132 | MAPKAPK3 | 0.55009954 |
| 133 | MTOR | 0.54995821 |
| 134 | LCK | 0.54935928 |
| 135 | DMPK | 0.53724603 |
| 136 | LRRK2 | 0.53230027 |
| 137 | CDK4 | 0.52808894 |
| 138 | CAMKK2 | 0.51735510 |
| 139 | LYN | 0.51573092 |
| 140 | CDC42BPA | 0.50390194 |
| 141 | RPS6KA3 | 0.49627278 |
| 142 | ROCK1 | 0.49393811 |
| 143 | JAK2 | 0.49047538 |
| 144 | IRAK2 | 0.48790298 |
| 145 | MARK3 | 0.48621824 |
| 146 | MARK2 | 0.47751681 |
| 147 | WNK1 | 0.47155632 |
| 148 | DAPK3 | 0.47110697 |
| 149 | ERBB2 | 0.43347608 |
| 150 | RPS6KA2 | 0.43022164 |
| 151 | MAP3K1 | 0.42900675 |
| 152 | SGK1 | 0.42239249 |
| 153 | MATK | 0.41050555 |
| 154 | PKN1 | 0.38705692 |
| 155 | FRK | 0.38456038 |
| 156 | ABL2 | 0.37435648 |
| 157 | TEC | 0.36593168 |
| 158 | CAMK2B | 0.36007917 |
| 159 | PRKACA | 0.35741962 |
| 160 | TESK1 | 0.35439591 |
| 161 | FGFR3 | 0.35267327 |
| 162 | DYRK1B | 0.34940719 |
| 163 | MAPK4 | 0.34437847 |
| 164 | FYN | 0.34105134 |
| 165 | ARAF | 0.34078316 |
| 166 | MAP3K8 | 0.32365754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.39081056 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18634079 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.16871731 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.87608827 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.70499916 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.66716165 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66110074 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.62221053 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.51810166 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.46252314 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.42397406 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.37129751 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35673448 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32683036 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.25897758 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.23229536 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.16192615 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13863634 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.12920282 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.11030716 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.76997333 |
| 22 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.75249844 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73753226 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.70670783 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.65939892 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65061154 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64466445 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.64282710 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.62215194 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.61802823 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60242431 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58189129 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57212264 |
| 34 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.55648685 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53588098 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53093728 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.50330676 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45657803 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38100195 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37962170 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.30727531 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29816146 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28165174 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27311108 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22843749 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22206481 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21096224 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20274372 |
| 49 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.18884337 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17153154 |
| 51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16405216 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.16289215 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.15569750 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15403017 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14909858 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09604899 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09431182 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09066752 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 1.07988208 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07337726 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07333521 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06792896 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05969612 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04727628 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04094068 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03631781 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02722338 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01532596 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00736675 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.99552772 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99505862 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98864486 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96932657 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96292525 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94835501 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94436867 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.93571986 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93208303 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.92420288 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90406902 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89460542 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.88053750 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88049777 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87797510 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.87350414 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86011788 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84622331 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84347866 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83840368 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.83733342 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.83209904 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83100700 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82593369 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81364891 |
| 95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81089097 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80598444 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.79454918 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77897576 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75828853 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75500940 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.75494851 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74858737 |
| 103 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73627156 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.72680985 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72453523 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.72290313 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71338363 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71204166 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.70472838 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69872899 |
| 111 | Measles_Homo sapiens_hsa05162 | 0.69857452 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67377498 |
| 113 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66949328 |
| 114 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66371504 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65900148 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65411313 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64488281 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.64130691 |
| 119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63746100 |
| 120 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63113923 |
| 121 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63091541 |
| 122 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62462231 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60562473 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60313823 |
| 125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60219163 |
| 126 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59110251 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.58481672 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.58342032 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56804514 |
| 130 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56292675 |
| 131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56235519 |
| 132 | Malaria_Homo sapiens_hsa05144 | 0.55218584 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55171011 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54685024 |
| 135 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53884527 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53658105 |
| 137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52878377 |
| 138 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52551379 |
| 139 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52546153 |
| 140 | Salivary secretion_Homo sapiens_hsa04970 | 0.52003886 |
| 141 | Allograft rejection_Homo sapiens_hsa05330 | 0.51842340 |
| 142 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51536739 |
| 143 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51375758 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51002036 |
| 145 | Insulin secretion_Homo sapiens_hsa04911 | 0.50383752 |
| 146 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50373472 |
| 147 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50318037 |
| 148 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50101284 |
| 149 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49067093 |
| 150 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48319480 |
| 151 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45691003 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44966111 |
| 153 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43375266 |
| 154 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.42913250 |
| 155 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42172273 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40989746 |
| 157 | Morphine addiction_Homo sapiens_hsa05032 | 0.40757206 |
| 158 | Renin secretion_Homo sapiens_hsa04924 | 0.39763090 |
| 159 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37566343 |
| 160 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.36748909 |
| 161 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.35879355 |
| 162 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34703423 |
| 163 | Long-term potentiation_Homo sapiens_hsa04720 | 0.32854831 |
| 164 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32269944 |
| 165 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31195108 |
| 166 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30742445 |
| 167 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30223389 |
| 168 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.30216749 |
| 169 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.29868378 |
| 170 | Prion diseases_Homo sapiens_hsa05020 | 0.29344644 |
| 171 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28252917 |
| 172 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27322910 |
| 173 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27157114 |
| 174 | Taste transduction_Homo sapiens_hsa04742 | 0.26953365 |
| 175 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24898664 |

